Sign inJoin waitlistJoin the waitlist

TM

Tomer Mark

Hematology & Oncology

Credentials: · · ·

History

Hematology and Medical Oncology
2005–2008
Internal Medicine
2002–2005
Cornell Univ Joan and Sanford I Weill Med Coll
1998–2002

Research

Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma
New England Journal of Medicine · 2016 · 1,242 citations
Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study
Leukemia · 2017 · 299 citations
Daratumumab plus bortezomib and dexamethasone versus bortezomib and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of CASTOR
Haematologica · 2018 · 225 citations

Ruben Niesvizky
27 papers
Roger Pearse
24 papers
MC
Morton Coleman
21 papers
PF
Peter Forsberg
17 papers · 1 as a fellow
Tsiporah Shore
16 papers
Adriana Rossi
15 papers · 2 as a fellow
Usama Gergis
14 papers
Daniel Sherbenou
13 papers
Koen van Besien
12 papers
Scott Ely
12 papers
KP
Karen Pekle
11 papers
Parameswaran Hari
11 papers

Clinical trials

Palbociclib in Combination With Lenalidomide and Dexamethasone for Multiple Myeloma
Principal investigator · Terminated · Phase 1
Weill Medical College of Cornell University
2014–2016